1989年美国FDA共批准23种新药上市,复审时间8～77个月。3个产品:盐酸氯米帕明、氯扎平、盐酸甲氟喹被FDA 评为最高等级1A 级,说明这些药品获得重要的疗效。3个是罕用药品,即甘西克洛维钠(ganciclovir sodium,DHPG)、盐酸司立吉林、甲氟喹。23种新药及其用途如下:·腺苷,Lyphomed、Medco Research 产,商品名Adenocard,用于治疗阵发性室上性心动过速。·盐酸氯米帕明(clomipramine HCl), In 1989 the United States FDA approved a total of 23 kinds of new drugs listed, the review time 8 to 77 months. Three products: clomipramine hydrochloride, clonazepam, mefloquine hydrochloride were rated by the FDA as the highest level 1A, indicating that these drugs have important effects. Three are rarely used drugs, namely ganciclovir sodium (ganciclovir sodium, DHPG), hydrochlorothiazide, mefloquine. The 23 new drugs and their uses are as follows: • Adenosine, Lyphomed, a product of Medco Research, under the trade name Adenocard, for the treatment of paroxysmal supraventricular tachycardia. Clomipramine HCl,